Key facts
- Eyas Medical Imaging’s last known valuation is $30.9M (Mar 2024).
- It has raised $34.5M across 3 recorded rounds; the latest was Seed Round ($2.2M) in Apr 2026.
- Notable investors include JobsOhio Ventures, CincyTech, KTECH Capital, U.S. Department of Health and Human Services.
- Eyas Medical Imaging has filed 7 Form Ds with the SEC since 2021, most recently May 2026 ($2.2M sold to 7 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Eyas Medical Imaging
Funding rounds
3 roundsAbout Eyas Medical Imaging
Developer of a magnetic resonance imaging (MRI) technology designed to serve neonatal patients. The company's technology visualizes the anatomy of premature and sick babies in neonatal intensive care units without the hazards of ionizing radiation, enabling clients to locate small objects with laser-like precision.
- Sector
- Healthcare
- HQ
- Cincinnati, OH, United States
- Founded
- 2014
- Employees
- 20
- Website
- eyasmri.com/
- Ownership
- Privately Held (backing)
Eyas Medical Imaging doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Eyas Medical Imaging shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Eyas Medical Imaging in its N-PORT filings yet. We sweep new filings monthly.